Literature DB >> 14585215

The primary phase of infection by pathogenic simian-human immunodeficiency virus results in disruption of the blood-brain barrier.

Edward B Stephens1, Dinesh K Singh, M Eric Kohler, Mollie Jackson, Erik Pacyniak, Nancy E J Berman.   

Abstract

Using the simian-human immunodeficiency virus (SHIV), we have investigated whether the blood-brain barrier (BBB) is compromised during the early stages of infection. Five macaques were inoculated with pathogenic SHIV(50OLNV) for 2 weeks at which time macaques were anesthetized, perfused with saline, and sacrificed. The brains were removed and examined for the disruption of the blood-brain barrier by immunohistochemical staining for the plasma protein fibrinogen in the neural parenchyma. Our results indicate a disruption of the BBB in the five of five macaques inoculated with SHIV(50OLNV) for 2 weeks. Zonula occludens 1 (ZO-1), which is a marker for the tight junctions formed by brain vascular endothelial cells, was largely absent in areas that showed fibrinogen deposition in all five macaques. To determine if the BBB integrity correlated with the initial stages of infection, the brains from two macaques were analyzed that had progressed to end-stage disease following inoculation with pathogenic SHIV(50OLNV) but developed no neuropathology and from two macaques that were inoculated with a gene-deleted, nonpathogenic virus (novpuSHIV(KU-1bMC33)) for over 1 year. Our results indicate that unlike the macaques sacrificed during the acute phase of infection, immunohistochemical staining for fibrinogen in the neural parenchyma was negative and ZO-1 staining was readily detected in the endothelial cells of the blood vessels. The results of this study indicate that the transient loss of BBB integrity is a function of the high level of virus replication that occurs during the acute phase of infection and provides important information on the early stages of lentivirus neuroinvasion.

Entities:  

Mesh:

Year:  2003        PMID: 14585215     DOI: 10.1089/088922203322493003

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice.

Authors:  Phil Lee; Jieun Kim; Rachel Williams; Rajat Sandhir; Eugene Gregory; William M Brooks; Nancy E J Berman
Journal:  Exp Neurol       Date:  2011-12-19       Impact factor: 5.330

2.  Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain.

Authors:  Kenta Matsuda; Que Dang; Charles R Brown; Brandon F Keele; Fan Wu; Ilnour Ourmanov; Robert Goeken; Sonya Whitted; Nadeene E Riddick; Alicia Buckler-White; Vanessa M Hirsch
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

3.  Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers.

Authors:  Gavin Ryan; Terence Grimes; Brenda Brankin; Mohamad J E M F Mabruk; Margaret J Hosie; Oswald Jarrett; John J Callanan
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

4.  S100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS.

Authors:  N A Renner; R K Redmann; T Moroney-Rasmussen; H A Sansing; P P Aye; P J Didier; A A Lackner; A G Maclean
Journal:  Neuropathol Appl Neurobiol       Date:  2012-04       Impact factor: 8.090

Review 5.  The role of monocytes and perivascular macrophages in HIV and SIV neuropathogenesis: information from non-human primate models.

Authors:  W-K Kim; X Avarez; K Williams
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 6.  Nonhuman primate models of NeuroAIDS.

Authors:  Rachel Williams; Sirosh Bokhari; Peter Silverstein; David Pinson; Anil Kumar; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

Review 7.  Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.

Authors:  Clarisa M Buckner; Aimée J Luers; Tina M Calderon; Eliseo A Eugenin; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2006-04-13       Impact factor: 4.147

8.  The blood-brain barrier in the cerebrum is the initial site for the Japanese encephalitis virus entering the central nervous system.

Authors:  Tsan-Hsiun Liu; Li-Ching Liang; Chien-Chih Wang; Huei-Chung Liu; Wei-June Chen
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

9.  Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

Authors:  Michael D Bobardt; Patrick Salmon; Lianchun Wang; Jeffrey D Esko; Dana Gabuzda; Milan Fiala; Didier Trono; Bernadette Van der Schueren; Guido David; Philippe A Gallay
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Blood-brain barrier pericytes as a target for HIV-1 infection.

Authors:  Luc Bertrand; Hyung Joon Cho; Michal Toborek
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.